Back
Range Cancer Therapeutics ETF Vs. RH Industry Stock Comparison
Sell
38
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.92
Seasonality Move:
-2.75%
Buy
55
RH
RH
Last Price:
339.30
Seasonality Move:
6.48%
Sell
38
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $14.94. The Score for CNCR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
RH (RH)
is a Buy
Is RH a Buy, Sell or Hold?
- The current RH [RH] share price is $339.69. The Score for RH is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- RH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $14.94
The current trend is moderately bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
RH Stock Price Chart
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 48 | Sell |
| Chaikin Money Flow: | 1445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.66 - 15.58) | Sell |
| Bollinger Bands (100): | (13.97 - 15.37) | Buy |
RH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.41 | Buy |
| Relative Strength Index (14 RSI): | 69.21 | Buy |
| Chaikin Money Flow: | -115341 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (248.63 - 330.37) | Buy |
| Bollinger Bands (100): | (239.3 - 298.92) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.31 | Sell |
| 20-day SMA: | 15.15 | Sell |
| 50-day SMA: | 14.83 | Buy |
| 200-day SMA: | 14.82 | Buy |
| 8-day EMA: | 15.19 | Sell |
| 20-day EMA: | 15.15 | Sell |
| 50-day EMA: | 14.91 | Buy |
| 200-day EMA: | 14.47 | Buy |
RH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 340.6 | Sell |
| 20-day SMA: | 293.49 | Buy |
| 50-day SMA: | 277.11 | Buy |
| 200-day SMA: | 271.37 | Buy |
| 8-day EMA: | 332.84 | Buy |
| 20-day EMA: | 308.36 | Buy |
| 50-day EMA: | 285.19 | Buy |
| 200-day EMA: | 274.1 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
RH Earnings Growth & RH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.58 per share, an increase next quarter of $1.42 per share, a decrease this year of $16.71 per share, and a decrease next year of $2.07 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
RH Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||